Reversal of pipecuronium bromide with pyridostigmine. 1995

R M Alisoglu, and J Nagelhout, and J V Kyff, and S Perov, and P W Santoro, and J Scarsella

Pipecuronium Bromide (Arduan, Organon, Inc, West Orange) is a long-acting, nondepolarizing neuromuscular blocking agent. The efficacy of pyridostigmine 170 micrograms/kg intravenously (approximately 10 mg/70 kg) for reversing pipecuronium has not been reported. This study was performed to determine the time required to obtain a train-of-four (TOF) ratio of 0.7 after administration of pyridostigmine 140 micrograms/kg at 25% recovery of T1 after pipecuronium-induced neuromuscular blockade. Sixteen, American Society of Anesthesiology (ASA) I or II patients undergoing surgical procedures of at least 90 minutes, requiring intubation and muscle relaxation were included. Neuromuscular blockade was assessed using the Puritan-Bennett/Datex NMT 221 placed for ulnar nerve stimulation. Anesthesia was maintained with a nitrous oxide/narcotic technique and the use of potent inhalational anesthetics was avoided. The mean reversal time was found to be 16.14 minutes, with a minimum of 10.3 minutes and a maximum of 24.3 minutes. The standard error was +/- 1.05 minutes with a variance of 17.68 minutes.

UI MeSH Term Description Entries
D008297 Male Males
D009407 Nerve Block Interruption of NEURAL CONDUCTION in peripheral nerves or nerve trunks by the injection of a local anesthetic agent (e.g., LIDOCAINE; PHENOL; BOTULINUM TOXINS) to manage or treat pain. Chemical Neurolysis,Chemodenervation,Nerve Blockade,Block, Nerve,Blockade, Nerve,Blockades, Nerve,Blocks, Nerve,Chemical Neurolyses,Chemodenervations,Nerve Blockades,Nerve Blocks,Neurolyses, Chemical,Neurolysis, Chemical
D009431 Neural Conduction The propagation of the NERVE IMPULSE along the nerve away from the site of an excitation stimulus. Nerve Conduction,Conduction, Nerve,Conduction, Neural,Conductions, Nerve,Conductions, Neural,Nerve Conductions,Neural Conductions
D011729 Pyridostigmine Bromide A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants. Mestinon,Pyridostigmine,Bromide, Pyridostigmine
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D004576 Electromyography Recording of the changes in electric potential of muscle by means of surface or needle electrodes. Electromyogram,Surface Electromyography,Electromyograms,Electromyographies,Electromyographies, Surface,Electromyography, Surface,Surface Electromyographies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

R M Alisoglu, and J Nagelhout, and J V Kyff, and S Perov, and P W Santoro, and J Scarsella
May 1991, British journal of hospital medicine,
R M Alisoglu, and J Nagelhout, and J V Kyff, and S Perov, and P W Santoro, and J Scarsella
January 1983, Acta chirurgica Hungarica,
R M Alisoglu, and J Nagelhout, and J V Kyff, and S Perov, and P W Santoro, and J Scarsella
January 1974, Anesthesia and analgesia,
R M Alisoglu, and J Nagelhout, and J V Kyff, and S Perov, and P W Santoro, and J Scarsella
June 1989, Anesthesia and analgesia,
R M Alisoglu, and J Nagelhout, and J V Kyff, and S Perov, and P W Santoro, and J Scarsella
March 1991, European journal of anaesthesiology,
R M Alisoglu, and J Nagelhout, and J V Kyff, and S Perov, and P W Santoro, and J Scarsella
December 1989, British journal of anaesthesia,
R M Alisoglu, and J Nagelhout, and J V Kyff, and S Perov, and P W Santoro, and J Scarsella
May 1992, Acta pharmaceutica Hungarica,
R M Alisoglu, and J Nagelhout, and J V Kyff, and S Perov, and P W Santoro, and J Scarsella
November 1955, The American journal of medicine,
R M Alisoglu, and J Nagelhout, and J V Kyff, and S Perov, and P W Santoro, and J Scarsella
February 1990, JAMA,
R M Alisoglu, and J Nagelhout, and J V Kyff, and S Perov, and P W Santoro, and J Scarsella
May 1992, Acta pharmaceutica Hungarica,
Copied contents to your clipboard!